Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ReShape Lifesciences Inc. (RSLS)
At close: 0.1739+0.0056 (+3.33%)
Pre-Market: 0.1999 +0.026 (+14.95%)
2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023
Company Reaffirms Commitment to Profitability
High Priority Search for Synergistic M&A Partner Continues
Company has no debt
IRVINE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced a 2024 cost reduction plan and reorganization to prioritize the commercialization of the company’s next generation, enhanced Lap-Band® 2.0 FLEX. Full implementation of the plan is expected to result in lower operating expenses of approximately $7.9 million in 2024 compared to $17.7 million in 2023, a 55.4% reduction, excluding one-time costs.
“ReShape remains committed to delivering shareholder value and, ultimately, profitability. Our continued focus on restructuring is intended to ensure the long-term sustainability and scalability of the Company,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. “As we considered the impact of GLP-1 prescriptions for weight loss treatment, which has put pressure on the bariatric industry, it was necessary to take a hard look at our operations and make significant cost reductions including a further reduction in staff, leading to a projected 55.4% decrease in operating expenses for 2024, compared to last year. This reorganization and decrease in expenses will allow us to focus on and optimize the commercialization of our physician-led redesigned Lap-Band® 2.0 FLEX, designed to improve the patient experience, which is currently in the early launch stage.
“At the same time, we continue our high priority search for synergistic M&A opportunities and, as previously reported, have engaged Maxim Group LLC, on an exclusive basis, to assist in this process. Finding the right partner will be key to the long-term success of ReShape Lifesciences. We look forward to providing further updates during our year end 2024 earnings call, later this month,” concluded Mr. Hickey.
About ReShape Lifesciences®
ReShape Lifesciences® is America’s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of Type 2 diabetes and metabolic disorders. The Obalon® balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit www.reshapelifesciences.com.
GDHG : Great news
NANPING, China, Feb. 29, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that on February 26, 2024, it entered into a Letter of Intent for Strategic Partnership ("LOI") with PT BESTAR JAYA ("BESTAR"), an Indonesian trading company that services large-scale supermarkets nationwide, to launch a total of 30 to 50 indoor amusement parks in Indonesia.
According to the terms of the LOI, BESTAR is expected to open indoor amusement parks in major shopping centers and supermarkets in prime locations across Indonesia, and Golden Heaven will offer planning, layout design, facility procurement, operational management, staff training and other related services to BESTAR. Further details of this partnership will be disclosed as the ongoing negotiation progresses.
Ms. Qiong Jin, the CEO and Chairman of the Company, commented, "We are honored to be a part of this major project with BESTAR. This partnership highlights our entry into the international market and our dedication to delivering pleasant entertainment experiences to our customers. We are committed to our global expansion strategy to enhance our competitiveness through strategic partnerships and business innovation. We are looking forward to carrying forward this partnership and bringing our entertainment resources to the Indonesian market."
About Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd. manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. With approximately 426,560 square meters of land in the aggregate, these parks are located in geographically diverse markets across the south of China and collectively offer approximately 139 rides and attractions. Due to the geographical locations of the parks and the ease of travel, the parks are easily accessible to an aggregate population of approximately 21 million people. Since September 30, 2023, Mangshi Jinsheng Amusement Park, which is one of the six parks, has been temporarily closed. The parks provide a wide range of exciting and entertaining experiences, including thrilling rides, family-friendly attractions, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.
GDHG : Great news
NANPING, China, Feb. 29, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that on February 26, 2024, it entered into a Letter of Intent for Strategic Partnership ("LOI") with PT BESTAR JAYA ("BESTAR"), an Indonesian trading company that services large-scale supermarkets nationwide, to launch a total of 30 to 50 indoor amusement parks in Indonesia.
According to the terms of the LOI, BESTAR is expected to open indoor amusement parks in major shopping centers and supermarkets in prime locations across Indonesia, and Golden Heaven will offer planning, layout design, facility procurement, operational management, staff training and other related services to BESTAR. Further details of this partnership will be disclosed as the ongoing negotiation progresses.
Ms. Qiong Jin, the CEO and Chairman of the Company, commented, "We are honored to be a part of this major project with BESTAR. This partnership highlights our entry into the international market and our dedication to delivering pleasant entertainment experiences to our customers. We are committed to our global expansion strategy to enhance our competitiveness through strategic partnerships and business innovation. We are looking forward to carrying forward this partnership and bringing our entertainment resources to the Indonesian market."
About Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd. manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. With approximately 426,560 square meters of land in the aggregate, these parks are located in geographically diverse markets across the south of China and collectively offer approximately 139 rides and attractions. Due to the geographical locations of the parks and the ease of travel, the parks are easily accessible to an aggregate population of approximately 21 million people. Since September 30, 2023, Mangshi Jinsheng Amusement Park, which is one of the six parks, has been temporarily closed. The parks provide a wide range of exciting and entertaining experiences, including thrilling rides, family-friendly attractions, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.
GDHG: 0.54
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173902061
+ on February 21, 2024, the Company's Board of Directors (the "Board") has authorized a share repurchase program authorizing the Company to repurchase up to US$6,000,000 of the Company's outstanding Class A ordinary shares from time to time during a 24-month period
time for a strong rebound:
Feb 23, 2024 0.4700 0.4910 0.4100 0.4730 0.4730 6,324,343
Feb 19, 2024 0.4900 0.5670 0.4100 0.4730 0.4730 18,373,200
Feb 12, 2024 0.5700 0.6100 0.4500 0.5040 0.5040 19,012,600
Feb 05, 2024 0.6100 0.7690 0.4850 0.5700 0.5700 6,939,200
Jan 29, 2024 0.5750 0.8470 0.5400 0.6060 0.6060 5,034,100
Jan 22, 2024 0.4600 0.5600 0.4410 0.5440 0.5440 1,475,100
Jan 15, 2024 0.5510 0.5600 0.4400 0.4510 0.4510 1,080,700
Jan 08, 2024 0.6060 0.6200 0.5390 0.5600 0.5600 2,384,400
Jan 01, 2024 0.7450 0.7450 0.6130 0.6240 0.6240 2,211,100
Dec 25, 2023 1.0900 1.1200 0.7020 0.7300 0.7300 6,992,700
Dec 18, 2023 1.2400 1.4900 1.0700 1.1400 1.1400 6,038,400
Dec 11, 2023 1.1700 1.5500 1.0500 1.2900 1.2900 9,870,200
Dec 04, 2023 19.5300 22.3000 1.3300 1.3600 1.3600 17,464,600
Nov 27, 2023 22.5200 24.8300 19.7500 20.5500 20.5500 1,834,400
Nov 20, 2023 21.8200 24.3000 19.7500 23.4900 23.4900 1,428,500
Nov 13, 2023 23.0000 24.9900 11.0050 20.3900 20.3900 2,547,300
GDHG: 0.54
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173902061
+ on February 21, 2024, the Company's Board of Directors (the "Board") has authorized a share repurchase program authorizing the Company to repurchase up to US$6,000,000 of the Company's outstanding Class A ordinary shares from time to time during a 24-month period
time for a strong rebound:
Feb 23, 2024 0.4700 0.4910 0.4100 0.4730 0.4730 6,324,343
Feb 19, 2024 0.4900 0.5670 0.4100 0.4730 0.4730 18,373,200
Feb 12, 2024 0.5700 0.6100 0.4500 0.5040 0.5040 19,012,600
Feb 05, 2024 0.6100 0.7690 0.4850 0.5700 0.5700 6,939,200
Jan 29, 2024 0.5750 0.8470 0.5400 0.6060 0.6060 5,034,100
Jan 22, 2024 0.4600 0.5600 0.4410 0.5440 0.5440 1,475,100
Jan 15, 2024 0.5510 0.5600 0.4400 0.4510 0.4510 1,080,700
Jan 08, 2024 0.6060 0.6200 0.5390 0.5600 0.5600 2,384,400
Jan 01, 2024 0.7450 0.7450 0.6130 0.6240 0.6240 2,211,100
Dec 25, 2023 1.0900 1.1200 0.7020 0.7300 0.7300 6,992,700
Dec 18, 2023 1.2400 1.4900 1.0700 1.1400 1.1400 6,038,400
Dec 11, 2023 1.1700 1.5500 1.0500 1.2900 1.2900 9,870,200
Dec 04, 2023 19.5300 22.3000 1.3300 1.3600 1.3600 17,464,600
Nov 27, 2023 22.5200 24.8300 19.7500 20.5500 20.5500 1,834,400
Nov 20, 2023 21.8200 24.3000 19.7500 23.4900 23.4900 1,428,500
Nov 13, 2023 23.0000 24.9900 11.0050 20.3900 20.3900 2,547,300
Jaguar Health Inc (jagx) : premarket: 0.07 + 0.01 (16.64%)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173919208
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173917616
I’m hoping for at least 0.1 (this week)
Jaguar health stock price in Germany: 0.0735 euro (x1.0844) = $0.0797
Jaguar Health Inc (jagx) : premarket: 0.07 + 0.01 (16.64%)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173919208
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173917616
I’m hoping for at least 0.1 (this week)
Jaguar health stock price in Germany: 0.0735 euro (x1.0844) = $0.0797
A month ago:
Jan 26, 2024 0.1410 0.1480 0.1110 0.1130 0.1130 104,343,500
Jan 25, 2024 0.1030 0.1190 0.0980 0.1150 0.1150 28,943,40
It's time shorters start to cover!!!
Settlement Date Short Interest Avg. Daily Share Volume Days to Cover
01/31/2024 4,111,288
01/12/2024 2,947,821
12/29/2023 708,904
Jagx: 0.06
52 Week Range 0.0510 - 2.3000
https://jaguar.health/pipeline/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173911094
Product revenue more than 10 million for 2023
Total assets $ 45,380,000
millions shares are short.
Free float of less than $2,500,000
Iliad Research & Trading LP : 4,875,000
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.6 %
Based on the 50,755,580 shares outstanding
Time for a very strong rebound:
Feb 23, 2024 0.0570 0.0619 0.0525 0.0600 0.0600 24,872,714
Feb 19, 2024 0.0720 0.0730 0.0510 0.0600 0.0600 82,160,200
Feb 12, 2024 0.0890 0.0960 0.0770 0.0780 0.0780 78,923,400
Feb 05, 2024 0.0960 0.0960 0.0770 0.0840 0.0840 62,062,300
Jan 29, 2024 0.1090 0.1160 0.0930 0.0970 0.0970 92,774,500
Jan 22, 2024 0.1020 0.1480 0.0950 0.1130 0.1130 163,317,200
Jan 15, 2024 0.0980 0.1070 0.0860 0.1010 0.1010 42,693,800
Jan 08, 2024 0.1400 0.1400 0.1020 0.1030 0.1030 74,868,000
Jan 01, 2024 0.1520 0.1560 0.1310 0.1400 0.1400 15,049,600
Dec 25, 2023 0.1700 0.1750 0.1500 0.1510 0.1510 14,160,900
Dec 18, 2023 0.1650 0.1680 0.1460 0.1670 0.1670 19,167,400
Dec 11, 2023 0.2250 0.2290 0.1510 0.1600 0.1600 38,737,500
Dec 04, 2023 0.3500 0.4050 0.2650 0.2650 0.2650 28,157,100
Nov 27, 2023 0.3600 0.3830 0.2910 0.3560 0.3560 15,147,500
Nov 20, 2023 0.4250 0.5140 0.3300 0.3740 0.3740 30,015,800
Nov 13, 2023 0.2980 0.4210 0.2850 0.4070 0.4070 20,367,600
Nov 06, 2023 0.3000 0.3370 0.2580 0.2920 0.2920 19,674,600
Oct 29, 2023 0.3310 0.3640 0.3170 0.3200 0.3200 13,055,100
Oct 22, 2023 0.3220 0.4000 0.3000 0.3250 0.3250 16,088,700
Oct 15, 2023 0.3200 0.3750 0.2100 0.3300 0.3300 45,452,000
Oct 08, 2023 0.2520 0.5290 0.2250 0.3200 0.3200 142,429,30
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.
Jagx: 0.06
52 Week Range 0.0510 - 2.3000
https://jaguar.health/pipeline/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173911094
Product revenue more than 10 million for 2023
Total assets $ 45,380,000
millions shares are short.
Free float of less than $2,500,000
Iliad Research & Trading LP : 4,875,000
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.6 %
Based on the 50,755,580 shares outstanding
Time for a very strong rebound:
Feb 23, 2024 0.0570 0.0619 0.0525 0.0600 0.0600 24,872,714
Feb 19, 2024 0.0720 0.0730 0.0510 0.0600 0.0600 82,160,200
Feb 12, 2024 0.0890 0.0960 0.0770 0.0780 0.0780 78,923,400
Feb 05, 2024 0.0960 0.0960 0.0770 0.0840 0.0840 62,062,300
Jan 29, 2024 0.1090 0.1160 0.0930 0.0970 0.0970 92,774,500
Jan 22, 2024 0.1020 0.1480 0.0950 0.1130 0.1130 163,317,200
Jan 15, 2024 0.0980 0.1070 0.0860 0.1010 0.1010 42,693,800
Jan 08, 2024 0.1400 0.1400 0.1020 0.1030 0.1030 74,868,000
Jan 01, 2024 0.1520 0.1560 0.1310 0.1400 0.1400 15,049,600
Dec 25, 2023 0.1700 0.1750 0.1500 0.1510 0.1510 14,160,900
Dec 18, 2023 0.1650 0.1680 0.1460 0.1670 0.1670 19,167,400
Dec 11, 2023 0.2250 0.2290 0.1510 0.1600 0.1600 38,737,500
Dec 04, 2023 0.3500 0.4050 0.2650 0.2650 0.2650 28,157,100
Nov 27, 2023 0.3600 0.3830 0.2910 0.3560 0.3560 15,147,500
Nov 20, 2023 0.4250 0.5140 0.3300 0.3740 0.3740 30,015,800
Nov 13, 2023 0.2980 0.4210 0.2850 0.4070 0.4070 20,367,600
Nov 06, 2023 0.3000 0.3370 0.2580 0.2920 0.2920 19,674,600
Oct 29, 2023 0.3310 0.3640 0.3170 0.3200 0.3200 13,055,100
Oct 22, 2023 0.3220 0.4000 0.3000 0.3250 0.3250 16,088,700
Oct 15, 2023 0.3200 0.3750 0.2100 0.3300 0.3300 45,452,000
Oct 08, 2023 0.2520 0.5290 0.2250 0.3200 0.3200 142,429,30
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including Short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops NP-300, a second-generation proprietary anti-secretory antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. The company was founded in 2013 and is headquartered in San Francisco, California.
GDHG: 0.48
They can buy the free float 🤑
Shares Outstanding 41.75M
Float 11.74M
NANPING, China, Feb. 22, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that on February 21, 2024, the Company's Board of Directors (the "Board") has authorized a share repurchase program authorizing the Company to repurchase up to US$6,000,000 of the Company's outstanding Class A ordinary shares from time to time during a 24-month period (the "Share Repurchase Program"). The Share Repurchase Program will be facilitated by Dawson James Securities, Inc.
The Board has determined that the Share Repurchase Program is in the best interest of the Company's shareholders based on its analysis and estimation that the current share price is significantly lower than the intrinsic value and that the Share Repurchase Program may improve shareholders' confidence in the Company. The Board will be periodically reviewing the Share Repurchase Program and may authorize adjustments of its terms and size.
In determining the amount of capital to allocate to share repurchases, the Company takes into account, among other things, its historical and expected business performance, cash and liquidity position, as well as global economic and market conditions and the market price of the Company's Class A ordinary shares. The timing, manner, price, and amount of any repurchases under the Share Repurchase Program are determined by the Company in its discretion. Purchases may be affected through open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or other means. The Company is not obligated to repurchase any specific number of Class A ordinary shares and the program may be modified, suspended, or discontinued at any time.
The Company intends to make all repurchases in compliance with applicable regulatory guidelines and to administer the plan in accordance with applicable laws.
About Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd. manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. With approximately 426,560 square meters of land in the aggregate, these parks are located in geographically diverse markets across the south of China and collectively offer approximately 139 rides and attractions. Due to the geographical locations of the parks and the ease of travel, the parks are easily accessible to an aggregate population of approximately 21 million people. Since September 30, 2023, Mangshi Jinsheng Amusement Park, which is one of the six parks, has been temporarily closed. The parks provide a wide range of exciting and entertaining experiences, including thrilling rides, family-friendly attractions, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.
GDHG: 0.48
They can buy the free float 🤑
Shares Outstanding 41.75M
Float 11.74M
NANPING, China, Feb. 22, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that on February 21, 2024, the Company's Board of Directors (the "Board") has authorized a share repurchase program authorizing the Company to repurchase up to US$6,000,000 of the Company's outstanding Class A ordinary shares from time to time during a 24-month period (the "Share Repurchase Program"). The Share Repurchase Program will be facilitated by Dawson James Securities, Inc.
The Board has determined that the Share Repurchase Program is in the best interest of the Company's shareholders based on its analysis and estimation that the current share price is significantly lower than the intrinsic value and that the Share Repurchase Program may improve shareholders' confidence in the Company. The Board will be periodically reviewing the Share Repurchase Program and may authorize adjustments of its terms and size.
In determining the amount of capital to allocate to share repurchases, the Company takes into account, among other things, its historical and expected business performance, cash and liquidity position, as well as global economic and market conditions and the market price of the Company's Class A ordinary shares. The timing, manner, price, and amount of any repurchases under the Share Repurchase Program are determined by the Company in its discretion. Purchases may be affected through open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or other means. The Company is not obligated to repurchase any specific number of Class A ordinary shares and the program may be modified, suspended, or discontinued at any time.
The Company intends to make all repurchases in compliance with applicable regulatory guidelines and to administer the plan in accordance with applicable laws.
About Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd. manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. With approximately 426,560 square meters of land in the aggregate, these parks are located in geographically diverse markets across the south of China and collectively offer approximately 139 rides and attractions. Due to the geographical locations of the parks and the ease of travel, the parks are easily accessible to an aggregate population of approximately 21 million people. Since September 30, 2023, Mangshi Jinsheng Amusement Park, which is one of the six parks, has been temporarily closed. The parks provide a wide range of exciting and entertaining experiences, including thrilling rides, family-friendly attractions, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.
Wish: 6.95
52w high 25.17
Time we see at least $8.
ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) announced that its Board of Directors (the “Board”) has unanimously approved an agreement to sell substantially all of its operating assets and liabilities, principally comprising its Wish ecommerce platform, to Qoo10, an ecommerce platform operating localized online marketplaces in Asia, for approximately $173 million in cash, subject to certain purchase price adjustments.
Following closing of the transaction, ContextLogic will have limited operating expenses and a balance sheet that will be debt-free, with net cash proceeds from the asset sale, approximately $2.7 billion of Net Operating Loss (“NOL”) carryforwards and certain retained assets. The Board intends to use the proceeds from the transaction to help monetize its NOLs. The Board also intends to explore the opportunity for a financial sponsor to help ContextLogic realize the value of its tax assets.
$173 million + 5% of $2.7 billion = $308 million : 24.230.000 shares = $12.72/share
Wish: 6.95
52w high 25.17
Time we see at least $8.
ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) announced that its Board of Directors (the “Board”) has unanimously approved an agreement to sell substantially all of its operating assets and liabilities, principally comprising its Wish ecommerce platform, to Qoo10, an ecommerce platform operating localized online marketplaces in Asia, for approximately $173 million in cash, subject to certain purchase price adjustments.
Following closing of the transaction, ContextLogic will have limited operating expenses and a balance sheet that will be debt-free, with net cash proceeds from the asset sale, approximately $2.7 billion of Net Operating Loss (“NOL”) carryforwards and certain retained assets. The Board intends to use the proceeds from the transaction to help monetize its NOLs. The Board also intends to explore the opportunity for a financial sponsor to help ContextLogic realize the value of its tax assets.
$173 million + 5% of $2.7 billion = $308 million : 24.230.000 shares = $12.72/share
Wish: Time we see at least $8.
ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) announced that its Board of Directors (the “Board”) has unanimously approved an agreement to sell substantially all of its operating assets and liabilities, principally comprising its Wish ecommerce platform, to Qoo10, an ecommerce platform operating localized online marketplaces in Asia, for approximately $173 million in cash, subject to certain purchase price adjustments.
Following closing of the transaction, ContextLogic will have limited operating expenses and a balance sheet that will be debt-free, with net cash proceeds from the asset sale, approximately $2.7 billion of Net Operating Loss (“NOL”) carryforwards and certain retained assets. The Board intends to use the proceeds from the transaction to help monetize its NOLs. The Board also intends to explore the opportunity for a financial sponsor to help ContextLogic realize the value of its tax assets.
$173 million + 5% of $2.7 billion = $308 million : 24.230.000 shares = $12.72/share
Wish: Time we see at least $8.
ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) announced that its Board of Directors (the “Board”) has unanimously approved an agreement to sell substantially all of its operating assets and liabilities, principally comprising its Wish ecommerce platform, to Qoo10, an ecommerce platform operating localized online marketplaces in Asia, for approximately $173 million in cash, subject to certain purchase price adjustments.
Following closing of the transaction, ContextLogic will have limited operating expenses and a balance sheet that will be debt-free, with net cash proceeds from the asset sale, approximately $2.7 billion of Net Operating Loss (“NOL”) carryforwards and certain retained assets. The Board intends to use the proceeds from the transaction to help monetize its NOLs. The Board also intends to explore the opportunity for a financial sponsor to help ContextLogic realize the value of its tax assets.
$173 million + 5% of $2.7 billion = $308 million : 24.230.000 shares = $12.72/share
GDHG: 0.503
Still a huge profit with a lots of assets and a collaboration with a main company in China. What else do you need from a new company?
Huge shareholders own 74%
https://www.otcmarkets.com/stock/GDHG/disclosure
SC 13G
When will we see $1 again???
Feb 12, 2024 0.5700 0.6100 0.4500 0.5040 0.5040 19,012,600
Feb 05, 2024 0.6100 0.7690 0.4850 0.5700 0.5700 6,939,200
Jan 29, 2024 0.5750 0.8470 0.5400 0.6060 0.6060 5,034,100
Jan 22, 2024 0.4600 0.5600 0.4410 0.5440 0.5440 1,475,100
Jan 15, 2024 0.5510 0.5600 0.4400 0.4510 0.4510 1,080,700
Jan 08, 2024 0.6060 0.6200 0.5390 0.5600 0.5600 2,384,400
Jan 01, 2024 0.7450 0.7450 0.6130 0.6240 0.6240 2,211,100
Dec 25, 2023 1.0900 1.1200 0.7020 0.7300 0.7300 6,992,700
Dec 18, 2023 1.2400 1.4900 1.0700 1.1400 1.1400 6,038,400
Dec 11, 2023 1.1700 1.5500 1.0500 1.2900 1.2900 9,870,200
Dec 04, 2023 19.5300 22.3000 1.3300 1.3600 1.3600 17,464,600
Nov 27, 2023 22.5200 24.8300 19.7500 20.5500 20.5500 1,834,400
Nov 20, 2023 21.8200 24.3000 19.7500 23.4900 23.4900 1,428,500
Nov 13, 2023 23.0000 24.9900 11.0050 20.3900 20.3900 2,547,300
GDHG: 0.503
Still a huge profit with a lots of assets and a collaboration with a main company in China. What else do you need from a new company?
Huge shareholders own 74%
https://www.otcmarkets.com/stock/GDHG/disclosure
SC 13G
When will we see $1 again???
Feb 12, 2024 0.5700 0.6100 0.4500 0.5040 0.5040 19,012,600
Feb 05, 2024 0.6100 0.7690 0.4850 0.5700 0.5700 6,939,200
Jan 29, 2024 0.5750 0.8470 0.5400 0.6060 0.6060 5,034,100
Jan 22, 2024 0.4600 0.5600 0.4410 0.5440 0.5440 1,475,100
Jan 15, 2024 0.5510 0.5600 0.4400 0.4510 0.4510 1,080,700
Jan 08, 2024 0.6060 0.6200 0.5390 0.5600 0.5600 2,384,400
Jan 01, 2024 0.7450 0.7450 0.6130 0.6240 0.6240 2,211,100
Dec 25, 2023 1.0900 1.1200 0.7020 0.7300 0.7300 6,992,700
Dec 18, 2023 1.2400 1.4900 1.0700 1.1400 1.1400 6,038,400
Dec 11, 2023 1.1700 1.5500 1.0500 1.2900 1.2900 9,870,200
Dec 04, 2023 19.5300 22.3000 1.3300 1.3600 1.3600 17,464,600
Nov 27, 2023 22.5200 24.8300 19.7500 20.5500 20.5500 1,834,400
Nov 20, 2023 21.8200 24.3000 19.7500 23.4900 23.4900 1,428,500
Nov 13, 2023 23.0000 24.9900 11.0050 20.3900 20.3900 2,547,300
GDHG: 0.5812 +0.0112 (+1.96%)
After hours: 0.8135 + 0.2323 (+39.97%)
$GDHG Nice AH pop (+40%) ✅ https://t.co/Mbo7OCh0cr pic.twitter.com/3CA0XzBMT5
— Quinten (@OTC_Quinten) February 12, 2024
$GDHG you have to be a fukkn clown to sell now. this will be back at 5+. china is going to pump this and destroy the shorts
— Luzifer Morningstar (@moonforreal) February 12, 2024
$GDHG 🏄♀️👏👇 https://t.co/pRrDLfURoH
— Jenn (@jennyjunechris) February 12, 2024
$GDHG - Looking ahead to 2024, our focus will be on Increasing our investment in technology to elevate visitor experiences and improve overall customer satisfaction.https://t.co/6MA5aaAcio
— papaspoppinpennys◻️ (@papaspoppinpeny) February 12, 2024
GDHG: 0.5812 +0.0112 (+1.96%)
After hours: 0.8135 + 0.2323 (+39.97%)
$GDHG Nice AH pop (+40%) ✅ https://t.co/Mbo7OCh0cr pic.twitter.com/3CA0XzBMT5
— Quinten (@OTC_Quinten) February 12, 2024
$GDHG you have to be a fukkn clown to sell now. this will be back at 5+. china is going to pump this and destroy the shorts
— Luzifer Morningstar (@moonforreal) February 12, 2024
$GDHG 🏄♀️👏👇 https://t.co/pRrDLfURoH
— Jenn (@jennyjunechris) February 12, 2024
$GDHG - Looking ahead to 2024, our focus will be on Increasing our investment in technology to elevate visitor experiences and improve overall customer satisfaction.https://t.co/6MA5aaAcio
— papaspoppinpennys◻️ (@papaspoppinpeny) February 12, 2024
Yessss
ASTROTECH CORP (ASTC) : 8.14
52w: 7 – 15.11
Shares Outstanding 5 1.7M
Float 1.21M
Total Cash Per Share (mrq) 22.03
Total Debt (mrq) 540k
Book Value Per Share (mrq) 25.82
AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2024, which ended December 31, 2023.
Financial Highlights & Recent Developments
• Year-to-date revenue totaled $1,540 thousand compared to $301 thousand in the comparative period in the prior year. This represents an increase of 512%. The growth was predominantly due to the Company successfully delivering on two previously announced purchase orders for TRACER 1000™ explosive trace detectors (ETDs) to customers in Romania.
• Astrotech’s consolidated balance sheet remains strong with $37 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets.
• Year-to-date fiscal year 2024 gross margin increased to 46% from 38% during the comparative period in the prior year, as we continue to benefit from the further refining and ruggedizing of our equipment.
• After the end of the quarter, 1st Detect reentered detection and non-detection testing with the U.S. Transportation Security Administration (TSA) for cargo security. Successful completion of TSA cargo detection testing is the final step to be listed on the Air Cargo Screening Technology List as an “approved” device. If approved, we believe the TRACER 1000 will be approved for cargo security screening sales in the United States.
• Pro-Control, Inc (Pro-Control) was launched December 12, 2023, and is focused on applying the Astrotech Mass Spectrometer Technology™ (AMS Technology) in chemical manufacturing process control applications developed by AgLAB. The Pro-Control Maximum Value Process™ and the Pro-Control-1000™ mass spectrometer are designed to test, measure and increase potency, purity and weight yields in the chemical manufacturing processes.
• Production and sales efforts continue for the AgLAB 1000-D2™, which utilizes the Maximum Value Process™. We exhibited it at this year’s MJ BizCon held late in the second quarter of fiscal year 2024.
“Fiscal year 2024 continued with strong sales at 1st Detect as we successfully fulfilled our two significant Tracer 1000 orders,” stated Thomas B. Pickens, III, Astrotech’s Chairman, Chief Executive Officer, and Chief Technology Officer. “We are gaining traction with the checkpoint market, especially with those customers looking to the future, by bringing the world’s first ECAC approved mass spectrometer ETD to their airports. Our ruggedized ETD brings the selectivity of a mass spectrometer to the checkpoint, and our customers have reported less false alarms while using our ETD compared to traditional IMS machines. This requires little to no additional training normally associated with using a traditional mass spectrometer. Further, the Pro-Control subsidiary was launched late this quarter and we look forward to introducing Pro-Control to chemical manufacturers who are using vacuum distillation,” stated Thomas B. Pickens, III.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Pro-Control is developing the mass spectrometry technology for use in chemical manufacturing processes. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
About the AgLAB-1000™, the BreathTest-1000™ and the Pro-Control-1000™
This press release contains information about our new products under development, AgLAB-1000, BreathTest-1000 and Pro-Control-1000. Product development involves a high degree of risk and uncertainty, and there can be no assurance that our new products will be successfully developed, achieve their intended benefits, receive full market authorization, or be commercially successful. In addition, FDA approval will be required to market BreathTest-1000 in the United States. Obtaining FDA approval is a complex and lengthy process, and there can be no assurance that FDA approval for BreathTest-1000 will be granted on a timely basis or at all.
Yessss
ASTROTECH CORP (ASTC) : 8.14
52w: 7 – 15.11
Shares Outstanding 5 1.7M
Float 1.21M
Total Cash Per Share (mrq) 22.03
Total Debt (mrq) 540k
Book Value Per Share (mrq) 25.82
AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2024, which ended December 31, 2023.
Financial Highlights & Recent Developments
• Year-to-date revenue totaled $1,540 thousand compared to $301 thousand in the comparative period in the prior year. This represents an increase of 512%. The growth was predominantly due to the Company successfully delivering on two previously announced purchase orders for TRACER 1000™ explosive trace detectors (ETDs) to customers in Romania.
• Astrotech’s consolidated balance sheet remains strong with $37 million in cash and liquid investments, which are anticipated to support our research and development, organic growth, and potential acquisition targets.
• Year-to-date fiscal year 2024 gross margin increased to 46% from 38% during the comparative period in the prior year, as we continue to benefit from the further refining and ruggedizing of our equipment.
• After the end of the quarter, 1st Detect reentered detection and non-detection testing with the U.S. Transportation Security Administration (TSA) for cargo security. Successful completion of TSA cargo detection testing is the final step to be listed on the Air Cargo Screening Technology List as an “approved” device. If approved, we believe the TRACER 1000 will be approved for cargo security screening sales in the United States.
• Pro-Control, Inc (Pro-Control) was launched December 12, 2023, and is focused on applying the Astrotech Mass Spectrometer Technology™ (AMS Technology) in chemical manufacturing process control applications developed by AgLAB. The Pro-Control Maximum Value Process™ and the Pro-Control-1000™ mass spectrometer are designed to test, measure and increase potency, purity and weight yields in the chemical manufacturing processes.
• Production and sales efforts continue for the AgLAB 1000-D2™, which utilizes the Maximum Value Process™. We exhibited it at this year’s MJ BizCon held late in the second quarter of fiscal year 2024.
“Fiscal year 2024 continued with strong sales at 1st Detect as we successfully fulfilled our two significant Tracer 1000 orders,” stated Thomas B. Pickens, III, Astrotech’s Chairman, Chief Executive Officer, and Chief Technology Officer. “We are gaining traction with the checkpoint market, especially with those customers looking to the future, by bringing the world’s first ECAC approved mass spectrometer ETD to their airports. Our ruggedized ETD brings the selectivity of a mass spectrometer to the checkpoint, and our customers have reported less false alarms while using our ETD compared to traditional IMS machines. This requires little to no additional training normally associated with using a traditional mass spectrometer. Further, the Pro-Control subsidiary was launched late this quarter and we look forward to introducing Pro-Control to chemical manufacturers who are using vacuum distillation,” stated Thomas B. Pickens, III.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Pro-Control is developing the mass spectrometry technology for use in chemical manufacturing processes. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
About the AgLAB-1000™, the BreathTest-1000™ and the Pro-Control-1000™
This press release contains information about our new products under development, AgLAB-1000, BreathTest-1000 and Pro-Control-1000. Product development involves a high degree of risk and uncertainty, and there can be no assurance that our new products will be successfully developed, achieve their intended benefits, receive full market authorization, or be commercially successful. In addition, FDA approval will be required to market BreathTest-1000 in the United States. Obtaining FDA approval is a complex and lengthy process, and there can be no assurance that FDA approval for BreathTest-1000 will be granted on a timely basis or at all.
Golden Heaven Group Holdings Ltd. (GDHG) :0.5101-0.0599 (-10.51%)
52 Week Range 0.4400 - 24.9900
Time for a strong rebound
Feb 12, 2024 0.5700 0.5719 0.5100 0.5122 0.5122 616,245
Feb 09, 2024 0.6210 0.6300 0.5550 0.5700 0.5700 1,434,500
Feb 08, 2024 0.6130 0.7690 0.5600 0.5870 0.5870 3,887,900
Feb 07, 2024 0.5220 0.5700 0.5100 0.5680 0.5680 878,800
Feb 06, 2024 0.5000 0.5710 0.5000 0.5330 0.5330 242,900
Feb 05, 2024 0.6100 0.6210 0.4850 0.4960 0.4960 493,900
Feb 05, 2024 0.6100 0.7690 0.4850 0.5700 0.5700 6,938,000
Jan 29, 2024 0.5750 0.8470 0.5400 0.6060 0.6060 5,034,100
Jan 22, 2024 0.4600 0.5600 0.4410 0.5440 0.5440 1,475,100
Jan 15, 2024 0.5510 0.5600 0.4400 0.4510 0.4510 1,080,700
Jan 08, 2024 0.6060 0.6200 0.5390 0.5600 0.5600 2,384,400
Jan 01, 2024 0.7450 0.7450 0.6130 0.6240 0.6240 2,211,100
Dec 25, 2023 1.0900 1.1200 0.7020 0.7300 0.7300 6,992,700
Dec 18, 2023 1.2400 1.4900 1.0700 1.1400 1.1400 6,038,400
Dec 11, 2023 1.1700 1.5500 1.0500 1.2900 1.2900 9,870,200
Dec 04, 2023 19.5300 22.3000 1.3300 1.3600 1.3600 17,464,600
Nov 27, 2023 22.5200 24.8300 19.7500 20.5500 20.5500 1,834,400
Nov 20, 2023 21.8200 24.3000 19.7500 23.4900 23.4900 1,428,500
Nov 13, 2023 23.0000 24.9900 11.0050 20.3900 20.3900 2,547,30
NANPING, China, Feb. 6, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, today released the following letter to shareholders from Ms. Qiong Jin, the CEO and Chairman of the Company.
https://finance.yahoo.com/news/golden-heaven-group-holdings-ltd-130000724.html
NANPING, China , Feb. 1, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, today announces the trial operation of Seven Rainbow Park (the "Park") in Anshun City, Guizhou Province.
https://finance.yahoo.com/news/golden-heaven-group-holdings-ltd-130000927.html
Golden Heaven Group Holdings Ltd. (GDHG) :0.5101-0.0599 (-10.51%)
52 Week Range 0.4400 - 24.9900
Time for a strong rebound
Feb 12, 2024 0.5700 0.5719 0.5100 0.5122 0.5122 616,245
Feb 09, 2024 0.6210 0.6300 0.5550 0.5700 0.5700 1,434,500
Feb 08, 2024 0.6130 0.7690 0.5600 0.5870 0.5870 3,887,900
Feb 07, 2024 0.5220 0.5700 0.5100 0.5680 0.5680 878,800
Feb 06, 2024 0.5000 0.5710 0.5000 0.5330 0.5330 242,900
Feb 05, 2024 0.6100 0.6210 0.4850 0.4960 0.4960 493,900
Feb 05, 2024 0.6100 0.7690 0.4850 0.5700 0.5700 6,938,000
Jan 29, 2024 0.5750 0.8470 0.5400 0.6060 0.6060 5,034,100
Jan 22, 2024 0.4600 0.5600 0.4410 0.5440 0.5440 1,475,100
Jan 15, 2024 0.5510 0.5600 0.4400 0.4510 0.4510 1,080,700
Jan 08, 2024 0.6060 0.6200 0.5390 0.5600 0.5600 2,384,400
Jan 01, 2024 0.7450 0.7450 0.6130 0.6240 0.6240 2,211,100
Dec 25, 2023 1.0900 1.1200 0.7020 0.7300 0.7300 6,992,700
Dec 18, 2023 1.2400 1.4900 1.0700 1.1400 1.1400 6,038,400
Dec 11, 2023 1.1700 1.5500 1.0500 1.2900 1.2900 9,870,200
Dec 04, 2023 19.5300 22.3000 1.3300 1.3600 1.3600 17,464,600
Nov 27, 2023 22.5200 24.8300 19.7500 20.5500 20.5500 1,834,400
Nov 20, 2023 21.8200 24.3000 19.7500 23.4900 23.4900 1,428,500
Nov 13, 2023 23.0000 24.9900 11.0050 20.3900 20.3900 2,547,30
NANPING, China, Feb. 6, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, today released the following letter to shareholders from Ms. Qiong Jin, the CEO and Chairman of the Company.
https://finance.yahoo.com/news/golden-heaven-group-holdings-ltd-130000724.html
NANPING, China , Feb. 1, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, today announces the trial operation of Seven Rainbow Park (the "Park") in Anshun City, Guizhou Province.
https://finance.yahoo.com/news/golden-heaven-group-holdings-ltd-130000927.html
WISH: 6.82
I hope we see $10/share before the end of this year. = $240.000.000
https://bnnbreaking.com/finance-nav/contextlogic-sells-wish-ecommerce-platform-to-qoo10-for-173-million
has agreed to sell its Wish ecommerce platform to Qoo10 for $173 million. The transaction aims to help ContextLogic monetize its $2.7 billion in Net Operating Losses (NOLs) and create new opportunities for value creation. The Board of Directors is also considering partnering with a financial sponsor to maximize the value of its tax assets.
Shares Outstanding 5 24.01M
Float 21.4M
Book Value Per Share (mrq) 11.33
WISH: 6.82
I hope we see $10/share before the end of this year. = $240.000.000
https://bnnbreaking.com/finance-nav/contextlogic-sells-wish-ecommerce-platform-to-qoo10-for-173-million
has agreed to sell its Wish ecommerce platform to Qoo10 for $173 million. The transaction aims to help ContextLogic monetize its $2.7 billion in Net Operating Losses (NOLs) and create new opportunities for value creation. The Board of Directors is also considering partnering with a financial sponsor to maximize the value of its tax assets.
Shares Outstanding 5 24.01M
Float 21.4M
Book Value Per Share (mrq) 11.33
UCAR Pre-Market Quotes Live
Consolidated Last Sale $0.1084 +0.0425 (+64.49%)
Pre-Market Volume 36,970,978
Pre-Market High $0.1444 (05:11:20 AM)
Pre-Market Low $0.0755 (04:12:06 AM)
some predict already 0.5
Total Cash (mrq) 108.97M
Total Cash Per Share (mrq) 2.08
Total Debt (mrq) 42.1M
Book Value Per Share (mrq) 4.95
UCAR Pre-Market Quotes Live
Consolidated Last Sale $0.1084 +0.0425 (+64.49%)
Pre-Market Volume 36,970,978
Pre-Market High $0.1444 (05:11:20 AM)
Pre-Market Low $0.0755 (04:12:06 AM)
some predict already 0.5
Total Cash (mrq) 108.97M
Total Cash Per Share (mrq) 2.08
Total Debt (mrq) 42.1M
Book Value Per Share (mrq) 4.95
U POWER LIMITED (UCAR) : 0.0712-0.0127 (-15.1371%)
Shorters play it smart
Feb 02, 2024 0.0900 0.0900 0.0820 0.0840 0.0840 17,937,800
Feb 01, 2024 0.0900 0.0950 0.0880 0.0910 0.0910 11,234,300
Jan 31, 2024 0.0960 0.0970 0.0870 0.0930 0.0930 19,426,000
Jan 30, 2024 0.1070 0.1100 0.0960 0.0980 0.0980 25,417,700
Jan 29, 2024 0.1080 0.1130 0.1050 0.1100 0.1100 13,007,400
Jan 26, 2024 0.1100 0.1160 0.1040 0.1090 0.1090 17,044,500
Jan 25, 2024 0.1200 0.1280 0.1050 0.1070 0.1070 30,236,600
Jan 24, 2024 0.1170 0.1180 0.1100 0.1140 0.1140 10,643,400
Jan 23, 2024 0.1240 0.1240 0.1130 0.1200 0.1200 14,519,900
Jan 22, 2024 0.1260 0.1350 0.1170 0.1270 0.1270 17,502,900
Jan 19, 2024 0.1100 0.1230 0.1060 0.1230 0.1230 16,257,000
Jan 18, 2024 0.1200 0.1200 0.1080 0.1120 0.1120 19,581,000
Jan 17, 2024 0.1230 0.1240 0.1160 0.1180 0.1180 24,858,700
Jan 16, 2024 0.1300 0.1680 0.1240 0.1260 0.1260 100,953,300
New York, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a best-efforts follow-on offering (the “Offering”) of 10,000,000 units at a purchase price of US$1.20 per unit for its client U Power Limited (Nasdaq: UCAR) (the “Company” or “U Power”), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China. Each unit consisted of one ordinary share of the Company, one Series A warrant to purchase one ordinary share of the Company, and one Series B warrant to purchase one ordinary share of the Company. The Series A warrants were immediately exercisable and will expire on the fifth anniversary of the original issuance date at an exercise price of US$1.20, and the Series B warrants were immediately exercisable and will expire on the fifth anniversary of the original issuance date at an exercise price of US$1.54.
The Company received aggregate gross proceeds of US$12,000,000 from the Offering, excluding expenses associated with the Offering. Proceeds from the Offering will be used for the merger and acquisition of battery swapping companies, working capital, and other general corporate purposes.
Univest Securities, LLC ("Univest") acted as the placement agent for the Offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. counsel to Univest in connection with the Offering.
U POWER LIMITED (UCAR) : 0.0712-0.0127 (-15.1371%)
Shorters play it smart
Feb 02, 2024 0.0900 0.0900 0.0820 0.0840 0.0840 17,937,800
Feb 01, 2024 0.0900 0.0950 0.0880 0.0910 0.0910 11,234,300
Jan 31, 2024 0.0960 0.0970 0.0870 0.0930 0.0930 19,426,000
Jan 30, 2024 0.1070 0.1100 0.0960 0.0980 0.0980 25,417,700
Jan 29, 2024 0.1080 0.1130 0.1050 0.1100 0.1100 13,007,400
Jan 26, 2024 0.1100 0.1160 0.1040 0.1090 0.1090 17,044,500
Jan 25, 2024 0.1200 0.1280 0.1050 0.1070 0.1070 30,236,600
Jan 24, 2024 0.1170 0.1180 0.1100 0.1140 0.1140 10,643,400
Jan 23, 2024 0.1240 0.1240 0.1130 0.1200 0.1200 14,519,900
Jan 22, 2024 0.1260 0.1350 0.1170 0.1270 0.1270 17,502,900
Jan 19, 2024 0.1100 0.1230 0.1060 0.1230 0.1230 16,257,000
Jan 18, 2024 0.1200 0.1200 0.1080 0.1120 0.1120 19,581,000
Jan 17, 2024 0.1230 0.1240 0.1160 0.1180 0.1180 24,858,700
Jan 16, 2024 0.1300 0.1680 0.1240 0.1260 0.1260 100,953,300
New York, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a best-efforts follow-on offering (the “Offering”) of 10,000,000 units at a purchase price of US$1.20 per unit for its client U Power Limited (Nasdaq: UCAR) (the “Company” or “U Power”), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China. Each unit consisted of one ordinary share of the Company, one Series A warrant to purchase one ordinary share of the Company, and one Series B warrant to purchase one ordinary share of the Company. The Series A warrants were immediately exercisable and will expire on the fifth anniversary of the original issuance date at an exercise price of US$1.20, and the Series B warrants were immediately exercisable and will expire on the fifth anniversary of the original issuance date at an exercise price of US$1.54.
The Company received aggregate gross proceeds of US$12,000,000 from the Offering, excluding expenses associated with the Offering. Proceeds from the Offering will be used for the merger and acquisition of battery swapping companies, working capital, and other general corporate purposes.
Univest Securities, LLC ("Univest") acted as the placement agent for the Offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. counsel to Univest in connection with the Offering.
UCAR: 0.0706-0.0133 (-15.8522%)
$UCAR IPO value was $3.9 billion ($75.00) with 52m shares in the OS on the IPO day of April 20th, 2023 less than 10 months ago
Market cap today: 4.4 million.
Shares Outstanding 62.5M
Total Cash (mrq) 108.97M
Total Debt (mrq) 42.1M
Book Value Per Share (mrq) 4.95
U Power Limited, together with its subsidiaries, engages in the development, manufacture, and sale of new energy vehicles and battery swapping stations in the People's Republic of China. It also offers battery swapping and sourcing, as well as technical and consultation services. The company was founded in 2013 and is headquartered in Anhui, the People's Republic of China.
UCAR: 0.0706-0.0133 (-15.8522%)
$UCAR IPO value was $3.9 billion ($75.00) with 52m shares in the OS on the IPO day of April 20th, 2023 less than 10 months ago
Market cap today: 4.4 million.
Shares Outstanding 62.5M
Total Cash (mrq) 108.97M
Total Debt (mrq) 42.1M
Book Value Per Share (mrq) 4.95
U Power Limited, together with its subsidiaries, engages in the development, manufacture, and sale of new energy vehicles and battery swapping stations in the People's Republic of China. It also offers battery swapping and sourcing, as well as technical and consultation services. The company was founded in 2013 and is headquartered in Anhui, the People's Republic of China.
VERIMATRIX SA (VMX) : 0,4465 + 0.095 (27.02%)
ISIN: FR0010291245
Verimatrix and Amazon Web Services Collaborate to Further Increase Speed and Reliability for OTT Content Security
February 01, 2024
Verimatrix announced collaboration with Amazon Web Services (AWS) to further bolster scalability, availability and ease of use for its Streamkeeper Multi-DRM cloud-based OTT content security platform. Streamkeeper Multi-DRM, a multi-tenant platform deployed on the AWS cloud, is compatible with AWS SPEKE to work seamlessly with AWS Media Services. It leverages AWS Global Accelerator and AWS Route 53 to allow lightning-speed content consumption, provide top-notch reliability, and consistently autoscale for peak events.
Additionally, AWS Shield, AWS WAF and AWS Key Management Service (KMS) ensure Streamkeeper Multi-DRM services enjoy powerful protections against malicious attacks. Top highlights of the collaboration include making OTT video services: Fast to deploy - Time spent building on-prem custom solutions delays the return on investment. Highly available and reliable - On-premises environments are either extremely costly (when they offer geo-redundancy), or not very reliable (when they don't).
Autoscaling - On-premises environments were typically over-provisioned in order to sustain consumption peaks. Powerfully secured - Entry-level DRMs do not meet the requirements of high-end content owners and therefore can restrict access to premium content. Integrated and compatible - missing integrations mean delays and project costs.
It's compatible with CMAF, CPIX and AWS SPEKE v2. Fully managed - Capturing metrics that can be monitored, alerted, and acted upon to provide a complete operational picture as well as visibility into service performance.
VERIMATRIX SA (VMX) : 0,4465 + 0.095 (27.02%)
ISIN: FR0010291245
Verimatrix and Amazon Web Services Collaborate to Further Increase Speed and Reliability for OTT Content Security
February 01, 2024
Verimatrix announced collaboration with Amazon Web Services (AWS) to further bolster scalability, availability and ease of use for its Streamkeeper Multi-DRM cloud-based OTT content security platform. Streamkeeper Multi-DRM, a multi-tenant platform deployed on the AWS cloud, is compatible with AWS SPEKE to work seamlessly with AWS Media Services. It leverages AWS Global Accelerator and AWS Route 53 to allow lightning-speed content consumption, provide top-notch reliability, and consistently autoscale for peak events.
Additionally, AWS Shield, AWS WAF and AWS Key Management Service (KMS) ensure Streamkeeper Multi-DRM services enjoy powerful protections against malicious attacks. Top highlights of the collaboration include making OTT video services: Fast to deploy - Time spent building on-prem custom solutions delays the return on investment. Highly available and reliable - On-premises environments are either extremely costly (when they offer geo-redundancy), or not very reliable (when they don't).
Autoscaling - On-premises environments were typically over-provisioned in order to sustain consumption peaks. Powerfully secured - Entry-level DRMs do not meet the requirements of high-end content owners and therefore can restrict access to premium content. Integrated and compatible - missing integrations mean delays and project costs.
It's compatible with CMAF, CPIX and AWS SPEKE v2. Fully managed - Capturing metrics that can be monitored, alerted, and acted upon to provide a complete operational picture as well as visibility into service performance.